Summary

The global market for Pharma Track and Trace Solutions was estimated to be worth US$ 2223 million in 2024 and is forecast to a readjusted size of US$ 6013 million by 2031 with a CAGR of 15.5% during the forecast period 2025-2031.
Track and trace solutions are not just economic measures for supply-chain efficiency. Experts estimate that 5% of all drugs sold worldwide are counterfeits – in some countries, figures even reach a shocking 50 %. Billions of products are “lost in the supply chain” every year. Counterfeit drugs and product diversion risk lives, undermine revenues, and threaten company reputations. The pharmaceutical industry needs to ensure supply-chain security and gain the ability to authenticate the ePedigree, or life history, of a product. Track and trace solutions are an essential part of this strategy. Track and trace solutions identify the origins of a pharmaceutical industry product and verify its authenticity. Moreover, track and trace solutions also help combat product diversion, whereby legitimate products are diverted from one market to another, with implications for licensing obligations and distribution agreements as well as for revenues.
The Pharma Track and Trace Solutions market is primarily driven by the growing global emphasis on pharmaceutical supply chain security and patient safety. Increasing incidences of counterfeit drugs flooding the market have pushed regulatory authorities worldwide to implement stringent serialization and traceability mandates, such as the U.S. Drug Supply Chain Security Act (DSCSA), the European Union Falsified Medicines Directive (FMD), and similar regulations in other regions. These regulatory requirements compel pharmaceutical companies to adopt advanced track and trace technologies to comply with legal standards and avoid penalties. Additionally, the rising complexity of global pharmaceutical supply chains, involving multiple stakeholders across geographies, necessitates robust solutions that provide end-to-end visibility and transparency. The adoption of innovative technologies like blockchain, RFID, and Internet of Things (IoT) further accelerates market growth by enhancing real-time monitoring capabilities and ensuring data integrity. Moreover, the increasing awareness among consumers and healthcare providers about drug authenticity and safety is creating demand for reliable tracking systems. Investments by pharmaceutical manufacturers and technology providers in developing cost-effective, scalable, and interoperable track and trace solutions also contribute significantly to market expansion.
Despite the promising growth prospects, the Pharma Track and Trace Solutions market faces several challenges that could impede its progress. One of the main hurdles is the high implementation cost associated with advanced track and trace technologies, especially for small and mid-sized pharmaceutical companies operating in emerging markets. The need for infrastructure upgrades, staff training, and integration with existing enterprise systems requires substantial capital and time investments, which may delay adoption. Furthermore, the lack of standardized global regulations and varying compliance requirements across countries create complexity and fragmentation, making it difficult for manufacturers to implement uniform solutions worldwide. Interoperability issues between different track and trace systems and data privacy concerns also pose significant barriers. Additionally, the constantly evolving tactics of counterfeiters and supply chain criminals require continuous innovation and updates to tracking solutions, increasing operational challenges. Resistance to change within traditional supply chain networks and the requirement for collaboration among diverse stakeholders further complicate deployment efforts. Addressing these challenges is critical for realizing the full potential of pharma track and trace systems in safeguarding the pharmaceutical supply chain and ensuring patient safety.
This report aims to provide a comprehensive presentation of the global market for Pharma Track and Trace Solutions, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Pharma Track and Trace Solutions by region & country, by Type, and by Application.
The Pharma Track and Trace Solutions market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharma Track and Trace Solutions.
Market Segmentation
By Company
Optel Vision
Siemens
IBM
Axway
Mettler-Toledo
Systech
SAP
Seidenader Maschinenbau
Antares Vision
Sea Vision
TraceLink
Adents International
Xyntek
Holoflex
ACG Worldwide
Segment by Type
Barcodes
RFID
Segment by Application
Bio Pharma
Chemical Pharma
Specially Pharma
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Pharma Track and Trace Solutions company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Pharma Track and Trace Solutions in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Pharma Track and Trace Solutions in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

ページTOPに戻る

Table of Contents

1 Market Overview
1.1 Pharma Track and Trace Solutions Product Introduction
1.2 Global Pharma Track and Trace Solutions Market Size Forecast (2020-2031)
1.3 Pharma Track and Trace Solutions Market Trends & Drivers
1.3.1 Pharma Track and Trace Solutions Industry Trends
1.3.2 Pharma Track and Trace Solutions Market Drivers & Opportunity
1.3.3 Pharma Track and Trace Solutions Market Challenges
1.3.4 Pharma Track and Trace Solutions Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Pharma Track and Trace Solutions Players Revenue Ranking (2024)
2.2 Global Pharma Track and Trace Solutions Revenue by Company (2020-2025)
2.3 Key Companies Pharma Track and Trace Solutions Manufacturing Base Distribution and Headquarters
2.4 Key Companies Pharma Track and Trace Solutions Product Offered
2.5 Key Companies Time to Begin Mass Production of Pharma Track and Trace Solutions
2.6 Pharma Track and Trace Solutions Market Competitive Analysis
2.6.1 Pharma Track and Trace Solutions Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Pharma Track and Trace Solutions Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharma Track and Trace Solutions as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Barcodes
3.1.2 RFID
3.2 Global Pharma Track and Trace Solutions Sales Value by Type
3.2.1 Global Pharma Track and Trace Solutions Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Pharma Track and Trace Solutions Sales Value, by Type (2020-2031)
3.2.3 Global Pharma Track and Trace Solutions Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Bio Pharma
4.1.2 Chemical Pharma
4.1.3 Specially Pharma
4.2 Global Pharma Track and Trace Solutions Sales Value by Application
4.2.1 Global Pharma Track and Trace Solutions Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Pharma Track and Trace Solutions Sales Value, by Application (2020-2031)
4.2.3 Global Pharma Track and Trace Solutions Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Pharma Track and Trace Solutions Sales Value by Region
5.1.1 Global Pharma Track and Trace Solutions Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Pharma Track and Trace Solutions Sales Value by Region (2020-2025)
5.1.3 Global Pharma Track and Trace Solutions Sales Value by Region (2026-2031)
5.1.4 Global Pharma Track and Trace Solutions Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Pharma Track and Trace Solutions Sales Value, 2020-2031
5.2.2 North America Pharma Track and Trace Solutions Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Pharma Track and Trace Solutions Sales Value, 2020-2031
5.3.2 Europe Pharma Track and Trace Solutions Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Pharma Track and Trace Solutions Sales Value, 2020-2031
5.4.2 Asia Pacific Pharma Track and Trace Solutions Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Pharma Track and Trace Solutions Sales Value, 2020-2031
5.5.2 South America Pharma Track and Trace Solutions Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Pharma Track and Trace Solutions Sales Value, 2020-2031
5.6.2 Middle East & Africa Pharma Track and Trace Solutions Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Pharma Track and Trace Solutions Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Pharma Track and Trace Solutions Sales Value, 2020-2031
6.3 United States
6.3.1 United States Pharma Track and Trace Solutions Sales Value, 2020-2031
6.3.2 United States Pharma Track and Trace Solutions Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Pharma Track and Trace Solutions Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Pharma Track and Trace Solutions Sales Value, 2020-2031
6.4.2 Europe Pharma Track and Trace Solutions Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Pharma Track and Trace Solutions Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Pharma Track and Trace Solutions Sales Value, 2020-2031
6.5.2 China Pharma Track and Trace Solutions Sales Value by Type (%), 2024 VS 2031
6.5.3 China Pharma Track and Trace Solutions Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Pharma Track and Trace Solutions Sales Value, 2020-2031
6.6.2 Japan Pharma Track and Trace Solutions Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Pharma Track and Trace Solutions Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Pharma Track and Trace Solutions Sales Value, 2020-2031
6.7.2 South Korea Pharma Track and Trace Solutions Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Pharma Track and Trace Solutions Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Pharma Track and Trace Solutions Sales Value, 2020-2031
6.8.2 Southeast Asia Pharma Track and Trace Solutions Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Pharma Track and Trace Solutions Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Pharma Track and Trace Solutions Sales Value, 2020-2031
6.9.2 India Pharma Track and Trace Solutions Sales Value by Type (%), 2024 VS 2031
6.9.3 India Pharma Track and Trace Solutions Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Optel Vision
7.1.1 Optel Vision Profile
7.1.2 Optel Vision Main Business
7.1.3 Optel Vision Pharma Track and Trace Solutions Products, Services and Solutions
7.1.4 Optel Vision Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
7.1.5 Optel Vision Recent Developments
7.2 Siemens
7.2.1 Siemens Profile
7.2.2 Siemens Main Business
7.2.3 Siemens Pharma Track and Trace Solutions Products, Services and Solutions
7.2.4 Siemens Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
7.2.5 Siemens Recent Developments
7.3 IBM
7.3.1 IBM Profile
7.3.2 IBM Main Business
7.3.3 IBM Pharma Track and Trace Solutions Products, Services and Solutions
7.3.4 IBM Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
7.3.5 IBM Recent Developments
7.4 Axway
7.4.1 Axway Profile
7.4.2 Axway Main Business
7.4.3 Axway Pharma Track and Trace Solutions Products, Services and Solutions
7.4.4 Axway Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
7.4.5 Axway Recent Developments
7.5 Mettler-Toledo
7.5.1 Mettler-Toledo Profile
7.5.2 Mettler-Toledo Main Business
7.5.3 Mettler-Toledo Pharma Track and Trace Solutions Products, Services and Solutions
7.5.4 Mettler-Toledo Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
7.5.5 Mettler-Toledo Recent Developments
7.6 Systech
7.6.1 Systech Profile
7.6.2 Systech Main Business
7.6.3 Systech Pharma Track and Trace Solutions Products, Services and Solutions
7.6.4 Systech Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
7.6.5 Systech Recent Developments
7.7 SAP
7.7.1 SAP Profile
7.7.2 SAP Main Business
7.7.3 SAP Pharma Track and Trace Solutions Products, Services and Solutions
7.7.4 SAP Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
7.7.5 SAP Recent Developments
7.8 Seidenader Maschinenbau
7.8.1 Seidenader Maschinenbau Profile
7.8.2 Seidenader Maschinenbau Main Business
7.8.3 Seidenader Maschinenbau Pharma Track and Trace Solutions Products, Services and Solutions
7.8.4 Seidenader Maschinenbau Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
7.8.5 Seidenader Maschinenbau Recent Developments
7.9 Antares Vision
7.9.1 Antares Vision Profile
7.9.2 Antares Vision Main Business
7.9.3 Antares Vision Pharma Track and Trace Solutions Products, Services and Solutions
7.9.4 Antares Vision Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
7.9.5 Antares Vision Recent Developments
7.10 Sea Vision
7.10.1 Sea Vision Profile
7.10.2 Sea Vision Main Business
7.10.3 Sea Vision Pharma Track and Trace Solutions Products, Services and Solutions
7.10.4 Sea Vision Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
7.10.5 Sea Vision Recent Developments
7.11 TraceLink
7.11.1 TraceLink Profile
7.11.2 TraceLink Main Business
7.11.3 TraceLink Pharma Track and Trace Solutions Products, Services and Solutions
7.11.4 TraceLink Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
7.11.5 TraceLink Recent Developments
7.12 Adents International
7.12.1 Adents International Profile
7.12.2 Adents International Main Business
7.12.3 Adents International Pharma Track and Trace Solutions Products, Services and Solutions
7.12.4 Adents International Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
7.12.5 Adents International Recent Developments
7.13 Xyntek
7.13.1 Xyntek Profile
7.13.2 Xyntek Main Business
7.13.3 Xyntek Pharma Track and Trace Solutions Products, Services and Solutions
7.13.4 Xyntek Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
7.13.5 Xyntek Recent Developments
7.14 Holoflex
7.14.1 Holoflex Profile
7.14.2 Holoflex Main Business
7.14.3 Holoflex Pharma Track and Trace Solutions Products, Services and Solutions
7.14.4 Holoflex Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
7.14.5 Holoflex Recent Developments
7.15 ACG Worldwide
7.15.1 ACG Worldwide Profile
7.15.2 ACG Worldwide Main Business
7.15.3 ACG Worldwide Pharma Track and Trace Solutions Products, Services and Solutions
7.15.4 ACG Worldwide Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
7.15.5 ACG Worldwide Recent Developments
8 Industry Chain Analysis
8.1 Pharma Track and Trace Solutions Industrial Chain
8.2 Pharma Track and Trace Solutions Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Pharma Track and Trace Solutions Sales Model
8.5.2 Sales Channel
8.5.3 Pharma Track and Trace Solutions Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer